These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 31695765)

  • 1. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
    Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
    Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
    Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
    BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.
    Oussalah A; Rischer S; Bensenane M; Conroy G; Filhine-Tresarrieu P; Debard R; Forest-Tramoy D; Josse T; Reinicke D; Garcia M; Luc A; Baumann C; Ayav A; Laurent V; Hollenbach M; Ripoll C; Guéant-Rodriguez RM; Namour F; Zipprich A; Fleischhacker M; Bronowicki JP; Guéant JL
    EBioMedicine; 2018 Apr; 30():138-147. PubMed ID: 29627389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
    Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
    Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma.
    Luo B; Ma F; Liu H; Hu J; Rao L; Liu C; Jiang Y; Kuangzeng S; Lin X; Wang C; Lei Y; Si Z; Chen G; Zhou N; Liang C; Jiang F; Liu F; Dai W; Liu W; Gao Y; Li Z; Li X; Zhou G; Li B; Zhang Z; Nian W; Luo L; Liu X
    BMC Med; 2022 Jan; 20(1):8. PubMed ID: 35027051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.
    Cai J; Chen L; Zhang Z; Zhang X; Lu X; Liu W; Shi G; Ge Y; Gao P; Yang Y; Ke A; Xiao L; Dong R; Zhu Y; Yang X; Wang J; Zhu T; Yang D; Huang X; Sui C; Qiu S; Shen F; Sun H; Zhou W; Zhou J; Nie J; Zeng C; Stroup EK; Zhang X; Chiu BC; Lau WY; He C; Wang H; Zhang W; Fan J
    Gut; 2019 Dec; 68(12):2195-2205. PubMed ID: 31358576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection.
    Wang P; Song Q; Ren J; Zhang W; Wang Y; Zhou L; Wang D; Chen K; Jiang L; Zhang B; Chen W; Qu C; Zhao H; Jiao Y
    Sci Transl Med; 2022 Nov; 14(672):eabp8704. PubMed ID: 36417488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of hepatocellular carcinoma via no end-repair enzymatic methylation sequencing of cell-free DNA and pre-trained neural network.
    Deng Z; Ji Y; Han B; Tan Z; Ren Y; Gao J; Chen N; Ma C; Zhang Y; Yao Y; Lu H; Huang H; Xu M; Chen L; Zheng L; Gu J; Xiong D; Zhao J; Gu J; Chen Z; Wang K
    Genome Med; 2023 Nov; 15(1):93. PubMed ID: 37936230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma detection via targeted enzymatic methyl sequencing of plasma cell-free DNA.
    Guo P; Zheng H; Li Y; Li Y; Xiao Y; Zheng J; Zhu X; Xu H; He Z; Zhang Q; Chen J; Qiu M; Jiang M; Liu P; Chen H
    Clin Epigenetics; 2023 Jan; 15(1):2. PubMed ID: 36600275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients.
    Choy LYL; Peng W; Jiang P; Cheng SH; Yu SCY; Shang H; Olivia Tse OY; Wong J; Wong VWS; Wong GLH; Lam WKJ; Chan SL; Chiu RWK; Chan KCA; Lo YMD
    Clin Chem; 2022 Sep; 68(9):1151-1163. PubMed ID: 35587130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies.
    Gonçalves E; Gonçalves-Reis M; Pereira-Leal JB; Cardoso J
    Sci Rep; 2022 Jul; 12(1):11512. PubMed ID: 35798798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma.
    Kim SC; Kim DW; Cho EJ; Lee JY; Kim J; Kwon C; Kim-Ha J; Hong SK; Choi Y; Yi NJ; Lee KW; Suh KS; Kim W; Kim W; Kim H; Kim YJ; Yoon JH; Yu SJ; Kim YJ
    Mol Cancer; 2023 Oct; 22(1):164. PubMed ID: 37803338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma.
    Park S; Lee EJ; Rim CH; Seong J
    Yonsei Med J; 2018 Jun; 59(4):470-479. PubMed ID: 29749129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of circulating cell-free DNA for hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhang J; Yuan Y; Gao S; Zhao X; Li H
    Biomark Med; 2021 Feb; 15(3):219-239. PubMed ID: 33470842
    [No Abstract]   [Full Text] [Related]  

  • 15. Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection.
    Fang Q; Yuan Z; Hu H; Zhang W; Wang G; Wang X
    Clin Epigenetics; 2023 Jul; 15(1):119. PubMed ID: 37501075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib.
    Oh CR; Kong SY; Im HS; Kim HJ; Kim MK; Yoon KA; Cho EH; Jang JH; Lee J; Kang J; Park SR; Ryoo BY
    BMC Cancer; 2019 Apr; 19(1):292. PubMed ID: 30935424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
    Cai Z; Zhang J; He Y; Xia L; Dong X; Chen G; Zhou Y; Hu X; Zhong S; Wang Y; Chen H; Xie D; Liu X; Liu J
    ESMO Open; 2021 Feb; 6(1):100021. PubMed ID: 33508734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
    Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
    Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics.
    Jiao J; Sanchez JI; Thompson EJ; Mao X; McCormick JB; Fisher-Hoch SP; Futreal PA; Zhang J; Beretta L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.
    Xu RH; Wei W; Krawczyk M; Wang W; Luo H; Flagg K; Yi S; Shi W; Quan Q; Li K; Zheng L; Zhang H; Caughey BA; Zhao Q; Hou J; Zhang R; Xu Y; Cai H; Li G; Hou R; Zhong Z; Lin D; Fu X; Zhu J; Duan Y; Yu M; Ying B; Zhang W; Wang J; Zhang E; Zhang C; Li O; Guo R; Carter H; Zhu JK; Hao X; Zhang K
    Nat Mater; 2017 Nov; 16(11):1155-1161. PubMed ID: 29035356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.